Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bonnet

Showing results (411-420 of 432) with videos related to

Pageof 44
Sort By:
Medical Oncology (Northwood, London, England)|November 6, 2010
Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysisM Bouchahda, T Macarulla, G Liedo, et al.
International Journal of Cardiology|November 12, 2024
Clinical impact of circulating biomarkers in prediction of adverse cardiac events in patients with congenital heart disease. A systematic reviewW J van Genuchten, H Averesch, Q M van Dieren, et al.
International Journal of Cardiology|November 20, 2015
Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension)M Beghetti, I Schulze-Neick, R M F Berger, et al.
Journal of Medical Genetics|April 10, 2009
Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia)S Romano, F Bajolle, V Valayannopoulos, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|November 9, 2020
[Prenatal path of care following the diagnosis of a malformation for which a novel prenatal therapy is available]S Hautier, E Kermorvant, N Khen-Dunlop, et al.
Leukemia|July 1, 2017
Preclinical modeling of myelodysplastic syndromesK Rouault-Pierre, S A Mian, M Goulard, et al.
American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 15, 2016
Anti-PD1-induced psoriasis: a study of 21 patientsJ Bonigen, C Raynaud-Donzel, J Hureaux, et al.
Gene Therapy|September 16, 2005
Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IXB W Bigger, E K Siapati, A Mistry, et al.
Leukemia|December 7, 2011
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemiaL Willems, N Chapuis, A Puissant, et al.
Pageof 44

Showing results (411-420 of 432) with videos related to

Sort By:
Pageof 44
Medical Oncology (Northwood, London, England)|November 6, 2010
Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysisM Bouchahda, T Macarulla, G Liedo, et al.
International Journal of Cardiology|November 12, 2024
Clinical impact of circulating biomarkers in prediction of adverse cardiac events in patients with congenital heart disease. A systematic reviewW J van Genuchten, H Averesch, Q M van Dieren, et al.
International Journal of Cardiology|November 20, 2015
Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension)M Beghetti, I Schulze-Neick, R M F Berger, et al.
Journal of Medical Genetics|April 10, 2009
Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia)S Romano, F Bajolle, V Valayannopoulos, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|November 9, 2020
[Prenatal path of care following the diagnosis of a malformation for which a novel prenatal therapy is available]S Hautier, E Kermorvant, N Khen-Dunlop, et al.
Leukemia|July 1, 2017
Preclinical modeling of myelodysplastic syndromesK Rouault-Pierre, S A Mian, M Goulard, et al.
American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 15, 2016
Anti-PD1-induced psoriasis: a study of 21 patientsJ Bonigen, C Raynaud-Donzel, J Hureaux, et al.
Gene Therapy|September 16, 2005
Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IXB W Bigger, E K Siapati, A Mistry, et al.
Leukemia|December 7, 2011
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemiaL Willems, N Chapuis, A Puissant, et al.
Pageof 44